David Geffen School Of Medicine is categorized under Medical Training Services in Los Angeles, CA and active since 2008.
David Geffen School Of Medicine was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Training Services business, which does work in the B2C market, and is classified as a Medical Training Services, under code number 611519 by the NAICS.
If you are seeking more information, feel free to contact David Ruben at the company’s single location by writing to 10945 Le Conte Avenue, Los Angeles, California CA 90024 or by phoning (310) 312-0531. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | David Geffen School Of Medicine |
Contact Person: | David Ruben |
Address: | 10945 Le Conte Avenue, Los Angeles, California 90024 |
Phone Number: | (310) 312-0531 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Training Services |
SIC Code: | 8249 |
NAICS Code: | 611519 |
Share This Business: |
David Geffen School Of Medicine was started in 2008 to provide professional Medical Training Services under the SIC code 8249 and NAICS code 611519. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David Ruben for inquiries that concern David Geffen School Of Medicine by calling the company number (310) 312-0531, as your correspondence is most welcome. Additionally, the physical location of the single location of David Geffen School Of Medicine can be found at the coordinates 34.063806,-118.446235 as well as the street address 10945 Le Conte Avenue in Los Angeles, California 90024.
For its online presence, you may visit David Geffen School Of Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.